SFRS3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.295600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.393800E-02
Normal-vs-Stage2
9.018300E-02
Normal-vs-Stage3
6.020000E-02
Normal-vs-Stage4
9.027400E-01
Stage1-vs-Stage2
6.172600E-01
Stage1-vs-Stage3
3.159800E-01
Stage1-vs-Stage4
1.116360E-01
Stage2-vs-Stage3
9.885700E-02
Stage2-vs-Stage4
8.159700E-02
Stage3-vs-Stage4
6.663800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.389800E-02
Normal-vs-AfricanAmerican
1.405780E-01
Normal-vs-Asian
6.620000E-02
Caucasian-vs-AfricanAmerican
9.486600E-01
Caucasian-vs-Asian
6.145800E-01
AfricanAmerican-vs-Asian
7.720200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.619800E-02
Normal-vs-Female
8.049700E-02
Male-vs-Female
9.688800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.645900E-02
Normal-vs-Age(41-60Yrs)
1.470220E-01
Normal-vs-Age(61-80Yrs)
7.700200E-02
Normal-vs-Age(81-100Yrs)
3.242500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.773840E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.644000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.736200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.001700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.384000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.964180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.486400E-02
Normal-vs-Daily Drinker
3.843600E-02
Normal-vs-Weekly Drinker
9.429800E-02
Normal-vs-Occasional Drinker
1.240610E-01
Normal-vs-Social Drinker
9.342200E-02
Non Drinker-vs-Daily Drinker
4.767400E-01
Non Drinker-vs-Weekly Drinker
9.750000E-01
Non Drinker-vs-Occasional Drinker
1.447560E-01
Non Drinker-vs-Social Drinker
9.541000E-01
Daily Drinker-vs-Weekly Drinker
5.766400E-01
Daily Drinker-vs-Occasional Drinker
3.487500E-02
Daily Drinker-vs-Social Drinker
5.088400E-01
Weekly Drinker-vs-Occasional Drinker
1.824230E-01
Weekly Drinker-vs-Social Drinker
9.388600E-01
Occasional Drinker-vs-Social Drinker
2.021000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.982200E-01
Normal-vs-Grade 2
5.320800E-01
Normal-vs-Grade 3
5.184800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.685900E-02
Grade 1-vs-Grade 3
5.653800E-02
Grade 1-vs-Grade 4
2.982200E-01
Grade 2-vs-Grade 3
6.293400E-01
Grade 2-vs-Grade 4
5.320800E-01
Grade 3-vs-Grade 4
5.184800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.086000E-02
Normal-vs-NonDiabetic
5.241900E-02
Diabetic-vs-NonDiabetic
5.264800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.234020E-01
Normal-vs-NoPancreatitis
6.707700E-02
Pancreatitis-vs-NoPancreatitis
6.608400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.230980E-01
Normal-vs-N1
8.058200E-02
N0-vs-N1
8.966600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.036420E-01
Normal-vs-TP53-NonMutant
1.708410E-01
TP53-Mutant-vs-TP53-NonMutant
1.684430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
